WalshBK, BetitP, FinkJB, PereiraLM, ArnoldJ. Characterization of ribavirin aerosol with small particle aerosol generator and vibrating mesh micropump aerosol technologies. Respir Care, 2016; 61(5):577–585.
2.
GuerguerianAM, GauthierM, LebelMH, FarrellCA, LacroixJ. Ribavirin in ventilated respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med, 1999; 160(3):829–834.
3.
ChuHY, RenaudC, FickenE, ThomsonB, KuypersJ, EnglundJA. Respiratory tract infections due to human metapneumovirus in immunocompromised children. J Pediatric Infect Dis Soc, 2014; 3(4):286–293.
4.
EgliA, BucherC, DumoulinA, SternM, BuserA, BubendorfL, et al. Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation. Infection, 2012; 40(6):677–684.
5.
DokosC, MasjosthusmannK, RellensmannG, WernerC, Schuler-LüttmannS, MüllerKM, et al. Fatal human metapneumovirus infection following allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis, 2013; 15(3):E97–E101.
6.
ShahDP, GhantojiSS, MulanovichVE, Ariza-HerediaEJ, ChemalyRF. Management of respiratory viral infections in hematopoietic cell transplant recipients. Am J Blood Res, 2012; 2(4):203–218.
7.
Molinos-QuintanaA, Pérez-de SotoC, Gómez-RosaM, Pérez-SimónJA, Pérez-HurtadoJM. Intravenous ribavirin for respiratory syncytial viral infections in pediatric hematopoietic SCT recipients. Bone Marrow Transplant, 2013; 48(2):265–268.
8.
KitanovskiL, KoprivaS, PokornM, DolničarMB, RajićV, StefanovićM, JazbecJ. Treatment of severe human metapneumovirus (hMPV) pneumonia in an immunocompromised child with oral ribavirin and IVIG. J Pediatr Hematol Oncol, 2013; 35(7):e311–e313.
9.
ShahdaS, CarlosWG, KielPJ, KhanBA, HageCA. The human metapneumovirus: a case series and review of the literature. Transpl Infect Dis, 2011; 13(3):324–328.
